TITLE

Is adjuvant chemotherapy for non-small cell lung cancer here to stay?

AUTHOR(S)
Warke, T. J.
PUB. DATE
September 2005
SOURCE
Thorax;Sep2005, Vol. 60 Issue 9, p729
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a study published in the "New England Journal of Medicine," regarding adjuvant chemotherapy for non-small cell lung cancer. In this study patients with completely resected stage II non-small cell lung cancer were randomised to either adjuvant chemotherapy with vinorelbine and cisplatin or to observation. The primary end point was overall median survival which was significantly prolonged in the chemotherapy group. Side effects from chemotherapy were seen in many patients, but in comparable numbers to other reports--there were two deaths and febrile neutropenia was documented in 7%.
ACCESSION #
18366924

 

Related Articles

  • Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now? Aapro, Matti; Crawford, Jeffrey; Kamioner, Didier // Supportive Care in Cancer;May2010, Vol. 18 Issue 5, p529 

    Updated international guidelines published in 2006 have broadened the scope for the use of granulocyte colony-stimulating factor (G-CSF) in supporting delivery of myelosuppressive chemotherapy. G-CSF prophylaxis is now recommended when the overall risk of febrile neutropenia (FN) due to regimen...

  • Evidence-Based Recommendations for Antimicrobial Use in Febrile Neutropenia in Japan: Executive Summary. Masaoka, Tohru // Clinical Infectious Diseases;7/1/2004 Supplement 1, Vol. 39, pS49 

    Presents the recommendations for febrile neutropenia management developed by experts from Japan in collaboration with consultants from the U.S. and Europe. Definition of febrile neutropenia; Modification of therapy during the first week of treatment; Algorithms for the initial management of...

  • Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer. Fujita, Masaki; Ouchi, Hiroshi; Inoue, Yuichi; Inoshima, Ichiro; Ohshima, Tsukasa; Yoshimura, Chikara; Wataya, Hiroshi; Kawasaki, Masayuki; Tokunaga, Shoji; Nakanishi, Yoichi // Journal of Infection & Chemotherapy (Springer Science & Business;Apr2010, Vol. 16 Issue 2, p113 

    Fever often occurs along with chemotherapy-induced neutropenia. This condition is referred to as febrile neutropenia (FN). Excellent guidelines for FN treatment have recently been published; however, there has so far been insufficient research concerning FN associated with solid tumors,...

  • Bevacizumab.  // Reactions Weekly;12/12/2009, Issue 1282, p13 

    The article describes the case of a 67-year-old man who acquired acute renal failure while undergoing chemotherapy with intravenous (IV) bevacizumab, paclitaxel and carboplatin for stage IV non-small cell lung cancer. His serum creatinine level went up, prompting the need for intermittent...

  • Itraconazole/lenalidomide interaction.  // Reactions Weekly;4/21/2012, Issue 1398, p24 

    The article describes the case of a 53-year-old woman who developed febrile neutropenia after being administered with lenalidomide, and subsequently developed infections associated with neutropenia caused by an interaction between itraconazole and lenalidomide.

  • Vinflunine.  // Reactions Weekly;Nov2015, Vol. 1577 Issue 1, p251 

    The article presents a case study of a patient with febrile neutropenia which developed after receiving vinflunine for pegfilgrastim.

  • Patterns of first-coded complications in acute episodes of lung cancer care. Cantsilieris, Gayle; Jackson, Terri; Street, Annette // Health Information Management Journal;2006, Vol. 35 Issue 1, p27 

    The objective of this research was to document the most common first-recorded adverse events of inpatient care for lung cancer in Victoria, Australia. The sample comprised record abstracts for 3642 admissions (overnight or longer) of adult patients with lung cancer, extracted from the Victorian...

  • Breast Cancer Update.  // PharmaWatch: Cancer;Apr2005, Vol. 4 Issue 4, p11 

    The article offers news briefs related to breast cancer. The phase II clinical trial conducted by Amgen showed that administering Neulasta or pegfilgrastim, reduce the incidence of febrile neutropenia, a serious complication of cancer chemotherapy associated with infection. Intarcia Therapeutics...

  • Voriconazole-induced psychosis in a case of acute myeloid leukemia with febrile neutropenia. Singh, Hemendra; Kilara, Nalini; Subramaniyan, Vyjayanthi; Thyloth, Murali // Indian Journal of Pharmacology;May/Jun2015, Vol. 47 Issue 3, p332 

    Voriconazole-induced psychosis is a rare side effect. It is important that clinicians are made aware of voriconazole-induced potential psychosis. We report a case of voriconazole-induced psychosis that responded to haloperidol.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics